88IV - Public company info - Immunotech Biopharm Ltd

Input the stock code or the company name

Immunotech Biopharm Ltd, 06978.HK - Cash Flow	2019-12	2018-12
Net Cash Flow from Operating Activities	-95,469	-44,079
Net Cash Flow from Return on Investments & Servicing of Finance	-2,622	-34,500
Interest Received	377	202
Interest Paid	-2,070	-1,135
Dividend Received	0	0
Dividend Paid	-929	-33,567
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	25,364	-50,602
Additions to Fixed Assets	-13,762	-35,070
Disposal of Fixed Assets	0	109
Increase in Investments	0	-50,000
Decrease in Investments	46,777	14,899
Net Cash Flow with Related Parties	65,349	251,699
Others	-73,000	-232,239
Net Cash Flow before Financing Activities	-72,727	-129,181
Net Cash Flow from Financing Activities	220,208	249,149
New Loans	0	0
Loans Repayment	-2,883	-2,204
Fixed Income/Debt Instruments	175,932	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	0	0
Net Cash Flow with Related Parties	65,349	251,699
Others	-18,190	-346
Increase(Decrease) in Cash & Cash Equivalents	147,481	119,968
Cash & Cash Equivalents at Beginning of Year	128,332	3,390
Net Cash Flow due to Change in Exchange Rate/Others	6,434	4,974
Cash & Cash Equivalents at End of Year	282,247	128,332
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Immunotech Biopharm Ltd , 06978.HK